Ke Wang

University of Wisconsin–Madison — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index2.8kcitations126works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(10), Cancer-related molecular mechanisms research(6), Cancer, Hypoxia, and Metabolism(6), Genomics, phytochemicals, and oxidative stress(6), RNA modifications and cancer(6)

Publications126 total

Supplementary Table 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 4 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 7 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 13 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 12 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 3 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 8 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Table 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 6 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 5 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 9 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 10 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 11 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
Supplementary Figure 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
2025Open Access
The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
Cancer Research·2025· 1 cited
Revealing GRP75-Mediated Mitochondrial Stability That Promotes Breast Cancer Survival through Subcellular Anchoring of 70 kDa Heat Shock Protein Inhibitors
Journal of Medicinal Chemistry·2025
Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs
British Journal of Cancer·2025Open Access
LncRNA PCED1B-AS1 facilitates cervical cancer progression via targeting miR-361-3p
Nucleosides Nucleotides & Nucleic Acids·2025
SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism
Cell Death and Differentiation·2025· 7 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Fanfan Zhou(5), Xue Zhu(4), Kai Zhang(4), Ling Zhu(4), Xiaofeng Zhang(3), Yanyan Jiang(3), Shan Xu(3), Xinyang Wang(3), Dalin He(3), Ranwei Li(3), Yiwei Chu(2), Cuiping Zhang(2), Xue Qin(2), Pengyuan Yang(2), Hongxiu Yu(2), Yang Gao(2), Kaijie Wu(2), Peng Guo(2), Lili Qian(2), Jiajun Zheng(2)